Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co ...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 6 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks via Yahoo Finance· 10 hours agoLooking at individual holdings, West Pharmaceutical Services Inc (WST) accounts for about 1.73% of...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Reuters· 1 day agoGossamer Bio said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 5 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
15 Best Places to Retire in Florida That You’ve Never Heard Of
Insider Monkey via Yahoo Finance· 6 days agoThis article takes a look at the 15 best places to retire in Florida that you’ve never heard of. If...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 5 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Top 25 Stocks in the S&P 500 by Index Weight Right Now
Insider Monkey via Yahoo Finance· 5 days agoIn this piece, we will take a look at the top 25 stocks in the S&P 500 by index weight right now. If...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 11 hours agoASCO 2024 oral presentation of darovasertib neoadjuvant UM Phase 2 investigator-sponsored trial on June 3rd, and targeting neoadjuvant UM update in over 30 patients from Phase 2 company-sponsored ...
Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
GuruFocus.com via Yahoo Finance· 4 days agoThe top holdings were 8.97% in Eli Lilly and Co (NYSE:LLY), 6.45% in UnitedHealth Group Inc...